- Report
- August 2024
- 135 Pages
Global
From €2668EUR$2,999USD£2,304GBP
- Report
- January 2024
- 120 Pages
Global
From €5294EUR$5,950USD£4,571GBP
- Report
- April 2023
- 160 Pages
Global
From €5294EUR$5,950USD£4,571GBP
- Report
- August 2024
- 177 Pages
Global
From €2224EUR$2,500USD£1,921GBP
- Report
- May 2024
- 178 Pages
Global
From €2224EUR$2,500USD£1,921GBP
- Report
- July 2023
- 110 Pages
Global
From €4004EUR$4,500USD£3,457GBP
- Report
- February 2023
- 120 Pages
Global
From €4004EUR$4,500USD£3,457GBP
- Report
- July 2024
- 150 Pages
Global
From €3336EUR$3,750USD£2,881GBP
- Report
- April 2025
- 85 Pages
Saudi Arabia
From €3114EUR$3,500USD£2,689GBP
- Report
- September 2024
- 82 Pages
India
From €3114EUR$3,500USD£2,689GBP
- Report
- August 2024
- 80 Pages
Japan
From €3114EUR$3,500USD£2,689GBP
- Report
- July 2024
- 180 Pages
Global
From €4004EUR$4,500USD£3,457GBP
- Report
- February 2024
- 115 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- February 2024
- 116 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- April 2023
- 117 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- February 2024
- 111 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- February 2024
- 130 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- February 2024
- 120 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- February 2024
- 120 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- August 2022
- 114 Pages
Global
From €4226EUR$4,750USD£3,649GBP

Pneumonia is an infectious disease caused by bacteria, viruses, or fungi that affects the lungs. It is one of the most common infectious diseases and is a leading cause of death worldwide. Infectious disease testing is used to diagnose and monitor the progression of pneumonia. Tests used to diagnose pneumonia include chest X-rays, sputum cultures, and blood tests. Treatment for pneumonia typically involves antibiotics, antivirals, and other medications.
The pneumonia market within the context of infectious disease testing is a rapidly growing market. It is driven by the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis. The market is expected to grow due to the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis.
Some companies in the pneumonia market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more